Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system
Samia Yazid(Hammersmith Medicines Research), Rod Flower(Queen Mary University of London), Lucy V. Norling(Queen Mary University of London)
Cited by 27
Related Papers
The development of COX2 inhibitors
|Nature Reviews Drug Discovery|2003|464
Lipocortin-1: cellular mechanisms and clinical relevance
|Trends in Pharmacological Sciences|1994|380
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
|British Journal of Pharmacology|2000|330
Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells
|British Journal of Pharmacology|2002|146
Lipocortin-1 and the control of arachidonic acid release in cell signalling
|Biochemical Pharmacology|1995|81